Pilot immunotherapy study with letetresgene autoleucel (lete-cel, GSK3377794)T-cells in New York esophageal squamous cell carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive advanced non-small cell lung cancer (NSCLC) either alone or in combination with pembrolizumab

Trial Identifier: 208471
Sponsor: GlaxoSmithKline
Collaborator:
Merck
Start Date: December 2018
Primary Completion Date: June 2022
Study Completion Date: November 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Canada, Ontario Toronto, Ontario, Canada, M5G 1X6
Canada, Québec Montréal, Québec, Canada, H2X 0A9
Netherlands AMSTERDAM, Netherlands, 1066 CX
Netherlands GRONINGEN, Netherlands, 9713 GZ
Netherlands ROTTERDAM, Netherlands, 3015 GD
Netherlands UTRECHT, Netherlands, 3584 CX
Spain Barcelona, Spain, 08035
Spain Madrid, Spain, 28050
Spain Madrid, Spain, 28040
United Kingdom London, United Kingdom, WC1E 6AG
United Kingdom Manchester, United Kingdom, M20 4BX
United States, California Duarte, California, United States, 91010
United States, California La Jolla, California, United States, 92093-0987
United States, California Sacramento, California, United States, 95817
United States, California Stanford, California, United States, 94305
United States, Colorado Denver, Colorado, United States, 80218
United States, Florida Hollywood, Florida, United States, 33021
United States, Georgia Atlanta, Georgia, United States, 30322
United States, Illinois Chicago, Illinois, United States, 60637
United States, Iowa Iowa City, Iowa, United States, 52242
United States, Kentucky Lexington, Kentucky, United States, 40536
United States, Maryland Baltimore, Maryland, United States, 21201
United States, Missouri Saint Louis, Missouri, United States, 63110
United States, New York New York, United States, 10065
United States, North Carolina Durham, North Carolina, United States, 27710
United States, Ohio Columbus, Ohio, United States, 43210
United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111
United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232
United States, Tennessee Nashville, Tennessee, United States, 37203
United States, Texas Houston, Texas, United States, 77030
United States, Utah Salt Lake City, Utah, United States, 84112-5550